Dementia prevention, intervention, and care

G Livingston, A Sommerlad, V Orgeta, SG Costafreda… - The lancet, 2017 - thelancet.com
Executive summary Acting now on dementia prevention, intervention, and care will vastly
improve living and dying for individuals with dementia and their families, and in doing so …

Defeating Alzheimer's disease and other dementias: a priority for European science and society

B Winblad, P Amouyel, S Andrieu, C Ballard… - The Lancet …, 2016 - thelancet.com
Executive summary Alzheimer's disease (AD) is the leading cause of dementia, and
because the primary risk factor for AD is old age, the prevalence of the disease is increasing …

[HTML][HTML] Neuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigms

KL Lanctôt, J Amatniek, S Ancoli-Israel… - Alzheimer's & Dementia …, 2017 - Elsevier
Neuropsychiatric symptoms (NPSs) are hallmarks of Alzheimer's disease (AD), causing
substantial distress for both people with dementia and their caregivers, and contributing to …

[HTML][HTML] Impact of person-centred care training and person-centred activities on quality of life, agitation, and antipsychotic use in people with dementia living in nursing …

C Ballard, A Corbett, M Orrell, G Williams… - PLoS …, 2018 - journals.plos.org
Background Agitation is a common, challenging symptom affecting large numbers of people
with dementia and impacting on quality of life (QoL). There is an urgent need for evidence …

Health outcomes of deprescribing interventions among older residents in nursing homes: a systematic review and meta-analysis

CH Kua, VSL Mak, SWH Lee - Journal of the American Medical Directors …, 2019 - Elsevier
Objectives Deprescribing is effective in addressing concerns relating to polypharmacy in
residents of nursing homes. However, the clinical outcomes of deprescribing interventions …

Management of behavioral and psychological symptoms in people with Alzheimer's disease: an international Delphi consensus

HC Kales, CG Lyketsos, EM Miller… - International …, 2019 - cambridge.org
Objectives: Behavioral and psychological symptoms of dementia (BPSD) are nearly
universal in dementia, a condition occurring in more than 40 million people worldwide …

Trends in diagnosis and treatment for people with dementia in the UK from 2005 to 2015: a longitudinal retrospective cohort study

K Donegan, N Fox, N Black, G Livingston… - The Lancet Public …, 2017 - thelancet.com
Background The objectives of this study were to describe changes in the proportion of
people diagnosed with dementia and the pharmacological treatments prescribed to them …

Patient engagement in research related to dementia: a scoping review

J Bethell, E Commisso, HM Rostad, M Puts… - …, 2018 - journals.sagepub.com
Patient 'engagement'or 'involvement'in health research broadly refers to including people
with lived experience (ie individuals with personal experience of a health issue and their …

Understanding neuropsychiatric symptoms in Alzheimer's disease: challenges and advances in diagnosis and treatment

A Pless, D Ware, S Saggu, H Rehman… - Frontiers in …, 2023 - frontiersin.org
Neuropsychiatric symptoms (NPS) in Alzheimer's disease (AD) affect up to 97% of AD
patients, with an estimated 80% of current AD patients experiencing these symptoms …

Withdrawal versus continuation of long‐term antipsychotic drug use for behavioural and psychological symptoms in older people with dementia

E Van Leeuwen, M Petrovic… - Cochrane Database …, 2018 - cochranelibrary.com
Background Antipsychotic agents are often used to treat neuropsychiatric symptoms (NPS)
in people with dementia although there is uncertainty about the effectiveness of their long …